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Abstract
Background: Reforms in the health-care sector, including the pharmacy sector, can have different rationales. The
Swedish pharmacies were prior to 2009 organized in a state-owned monopoly. In 2009, a liberalization of the
ownership took place, in which a majority of the pharmacies were sold to private owners. The rationales for this
liberalization changed profoundly during the preparatory work, making it probable that other rationales than the
ones first expressed existed. The aim of this study was to explore the underlying rationales (not stated in official
documents) for the liberalization in the Swedish pharmacy sector, and also to compare the expectations with the
perceived outcomes.
Methods: Semi-structured interviews were conducted with representatives from key stakeholder organizations; i.e.,
political, patient, and professional organizations. The analysis was performed in steps, and themes were developed
in an inductive manner.
Results: One expectation among the political organization participants was that the ownership liberalization would
create opportunities for ideas. The competition introduced in the market was supposed to lead to a more
diversified pharmacy sector. After the liberalization, the participants in favor of the liberalization were surprised that
the pharmacies were so similar.
Among the professional organization participants, one important rationale for the liberalization was to get better
use of the pharmacists’ knowledge. However, all the professional, and some of the patient organization participants,
thought that the counseling in the pharmacies had deteriorated after the liberalization.
As expected in the interviews, the post-liberalization pharmacy sector consists of more pharmacies. However, an
unexpected perceived effect of the liberalization was, among participants from all the stakeholder groups, less
access to prescription medicines in the pharmacies.
Conclusions: This study showed that the political organization participants had an ideological basis for their
opinion. The political stakeholders did not have a clear view about what the liberalization should lead to, apart
from abolishing the monopoly. The perceived effects are quite similar in the different stakeholder groups, and not
as positive as were expected.
Keywords: Community pharmacy, Regulation, Pharmacy policy, Sweden
Abbreviation: NPM, New Public Management
* Correspondence: kristin.wisell@farmaci.uu.se
1Department of Pharmacy, Uppsala University, Box 580S-751 23 Uppsala,
Sweden
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wisell et al. BMC Health Services Research  (2016) 16:379 
DOI 10.1186/s12913-016-1637-6
Background
Reforms in the health-care sector, including the phar-
macy sector, could have different rationales. In some
cases, there are obvious problems that need to be solved.
Sometimes, the rationales are more ideological. Vogler
et al. [1] point out four major reasons for policy changes
in the pharmacy sector, i.e.,: 1) changes in the role of
pharmacists towards more health-related services. This
is in line with the pharmaceutical care movement but is
also connected to the expansion of self-care, including
more medicines being switched from prescription to
non-prescription; 2) economic reasons—e.g., changes in
the reimbursement system for pharmacies—either to
introduce reimbursement for new services, or diminish
the reimbursement; 3) policies related to the overall
pharmaceutical system— e.g., a change in which generic
versions that are reimbursed; and 4) the amount of regu-
lations is per se seen as a way to pursue certain ratio-
nales. One example is that of accessibility. Those in
favor of more regulations could argue that increased ac-
cessibility would be obtained with more regulations on
establishment, since the pharmacies will be more evenly
distributed over the country. Those against could argue
that less regulation (liberalization) leads to more phar-
macies, resulting in increased accessibility.
The pharmacy sector is highly regulated in most coun-
tries. This includes ownership, establishment, quality
control systems and margins [2]. Pharmaceutical pol-
icies, in this case the rules and regulations surrounding
the pharmacy sector, have an impact on how, and how
well, the sector works, and hence in the long run also on
the health of the population. Discussions about and
changes in pharmaceutical policy is an ongoing trend in
Europe, with changes taking place in many countries [1].
Some of the more comprehensive reforms have included
liberalization of ownership of pharmacies in Iceland and
Norway (both from systems with pharmacist-owned
pharmacies) and most recently in Sweden (from a state-
owned monopoly pharmacy chain).
The moves toward privatization can be considered as
New Public Management (NPM) reforms. NPM is a
term introduced in 1991 by Hood [3], describing a
worldwide trend of reforms in the public sector. Refor-
mation has been done in a broad range of areas, includ-
ing schools and the health-care sector [4, 5]. An
important characteristic of NPM is that organizations
operated by the state are seen as less effective, making
privatization the gold standard [6]. NPM can be seen as
a reaction to previous bureaucratic, expensive, and cen-
tralized public sector organizations [3]. The competition
introduced is expected to lead to more cost-effective or-
ganizations, price pressure, and more value for money.
Another idea behind NPM is to empower the public ser-
vice user, by enabling her/him to choose from different
providers [7, 8]. Also, when the public organizations are
divided and the decisions are made at lower levels, new
ideas and innovations are supposed to develop [9].
Prior to 2009, there was a state-owned pharmacy mon-
opoly to sell all medicines in Sweden. All community
pharmacies were organized in one pharmacy chain. The
liberalization in 2009 removed almost all ownership re-
strictions, allowing anyone who does not prescribe or
produce medicines to own pharmacies. Also, there are
no regulations on geographical establishment. Prior to
the liberalization reform Sweden had 929 community
pharmacies; now the pharmacy sector consists of about
1350 pharmacies. Approximately 165 are run by (mostly
single) entrepreneurs, and around 370 pharmacies are
still owned by the state [10]. The rest are in large phar-
macy chains, owned by private equity firms. From an
initial six privately-owned pharmacy chains, there are
now three privately-owned chains in the pharmacy
sector [11].
Two other reforms were introduced the same year
(2009). The first was a reform on non-prescription medi-
cines where specific non-prescription medicines were
allowed to be sold outside pharmacies, as long as the
owner of the establishment selling them reported this to
the authorities [12]. The second was a reform on generic
substitution (generic substitution as such already
existed). The reform implied that patients had to pay the
whole price, if they chose anything other than the cheap-
est generic medicine [13]. The generics reform was con-
sidered necessary in order to get an increase in the
number of pharmacies after the liberalization; the money
saved on the reform was used to increase the reimburse-
ment to pharmacies [14].
All three reforms were initiated by the center-right
government. The funding is still mostly public with add-
itional co-payments from patients.
After the liberalization reforms, governmental agencies
and researchers have investigated some of the effects, in-
cluding consumer satisfaction, costs, and work satisfac-
tion. Some of these investigations show a negative
impact on accessibility of medicine and work satisfaction
[15–17].
The Swedish pharmacy monopoly was considered to
function quite well [18], and there were no obvious com-
plaints from governmental agencies, or from the popula-
tion. Despite this, the monopoly was abolished in 2009,
and a pharmacy sector with almost no ownership regula-
tions was created. The change was more comprehensive
and far-reaching than most other pharmacy reforms that
were taking place in other European countries at the
same time.
The rationales for the ownership liberalization in
Sweden were unclear [19]. It seems as though the polit-
ical rationales [20] for the liberalization were originally
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economic but that to reduce regulations, was the domin-
ant one in the end [19]. These great changes make it in-
teresting to find out how politicians and other key
stakeholders view a liberalization reform in retrospect.
How do involved stakeholders, being part of the political
process, regard the changes caused by the liberalization?
The aim of this study was to explore the underlying
rationales (not necessarily stated in official documents)
for the liberalization of ownership in the Swedish phar-
macy sector, and also to compare the expectations with
the perceived outcomes.
Method
In order to explore the underlying rationales for the
liberalization, a qualitative study using semi structured
interviews was used. Qualitative interviews were per-
formed with key stakeholders. The organizations chosen
for interviews represented the key actors in the Swedish
pharmacy sphere, those which were important in the de-
bate and the formation of the liberalization reform. By
asking the group of people at the “inner core” of the
liberalization of the ownership regulations in the com-
munity pharmacy sector, knowledge about the political
process not accessible through studying formal docu-
ments can be obtained.
In order to decide which stakeholder organizations to
include in the study, written responses from stakeholder
organizations on the Swedish Government Official Re-
port were studied, and organizations showing engage-
ment through many or strong opinions were chosen.
Also, to further increase the chances of choosing adequate
stakeholders, a pharmacy market consultant involved in
the process was interviewed before the commencement of
data gathering, and the consultant also pointed out orga-
nizations that were especially engaged in the process.
Later, snowballing (via interviewees) was used to add orga-
nizations. This combination of purposeful sampling and
snowball sampling [21] increases the probability of obtain-
ing the most adequate sample [22].
The chosen organizations (see Table 1) were contacted
per e-mail and, if they agreed to participate, asked to in-
dicate the appropriate person in their organization, typ-
ically the most knowledgeable about the liberalization.
The participant was then contacted by phone to agree
on time and place for the interview. The participants
were informed of the aims of the study, and that the
interviewer is a licensed pharmacist and a doctoral
candidate.
A semi-structured interview protocol with open-ended
questions was constructed based on the study aim and
research done on the preparatory work [12]. The inter-
view protocol was modified slightly in regard to the dif-
ferent participants. For example, the organizations were
asked to elaborate on their specific expectations of the
pharmacy sector, and especially those mentioned in each
organization’s consultation responses. These directed
questions were used to diminish recall bias. The num-
bers of questions ranged from 14 to 20, whereof 13 were
the same to all participants. To clarify issues, probing
questions were also used.
Table 1 The organizations included and their attitudes to the liberalization reform before introductiona
Stakeholder organizations Notes Attitude toward the liberalization
of ownership before the reform
(according to the Committee
Report responses and the interviews)
National Pensioners’ Organization (PRO) Organization for senior citizens Negative
The Swedish Association for Senior Citizens (SPF) Organization for senior citizens Positive
The Swedish Rheumatism Association
(Reumatikerförbundet)
Organization for rheumatism patients Positive
New Conservatives (Moderaterna) Governmental party at the time of the reform Positive
The Liberal Party of Sweden (Folkpartiet) Governmental party at the time of the reform Positive
The Centre Party (Centerpartiet) Governmental party at the time of the reform Positive
The Christian Democrats (Kristdemokraterna) Governmental party at the time of the reform Positive
The Social Democrats (Socialdemokraterna) Non-governmental political organization
(Opposition party at the time of the reform)
Negative
Swedish Association of Local Authorities and Regions
(SKL)
Non-governmental political organization
(The umbrella organization of the local governments)
Neutral
Swedish Pharmaceutical Society (Apotekarsocieteten) The goal of the organization is to further
pharmaceutical research and to promote
high professional standards.
Neutral
The Swedish Pharmaceutical Union (Farmaciförbundet) Labor union Negative
The Swedish Pharmacists (Sveriges farmaceuter) Labor union Positive
aThe digit after each quotation does not correspond to the order in which the organizations are presented in Table 1
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The overall themes in the interviews were the views
and rationales for the pharmacy ownership liberalization
reform and the perceived effects of the liberalization.
Other themes were perceived effects on the health of the
population, and the future roles of the community phar-
macies and the pharmacist. Questions asked was e.g.,
what their organization expected from the liberalization
of ownership, and their views on how the liberalization
had influenced the pharmacies. The interviews were per-
formed face-to-face in a single session, at places chosen
by the participants, mostly at their workplaces. Some of
the participants had met the interviewer (in other con-
texts) prior to the commencement of the study. Only
the interviewer and the participant were present at the
time of the interviews.
The interviews lasted between 35 and 60 min, and
were audio-recorded and transcribed verbatim. Field
notes were also taken during the interviews. The pa-
rticipants were recruited between February 2013 and
September 2013, and interviews were conducted be-
tween March 2013 and October 2013.
The interview study was designed by a multi-professional
team, consisting of one pharmacist (first author) and two
social scientists with long experience of qualitative research
(including one political scientist). An interviewer with inter-
viewing experience (first author) conducted all interviews.
The analysis was an inductive content analysis [21, 23]
performed in several steps. After four interviews the first
and last author read the transcripts and identified tenta-
tive themes, first independently, and then in a consensus
meeting [23, 24]. This was repeated after eight, ten, and
finally after all interviews were done. Modifications of
the themes were made after each round. After ten inter-
views, the interview material was divided into two over-
all topics: expectations and perceived effects of the
liberalization of the Swedish pharmacy sector, and views
on the role of community pharmacists. This article deals
only with the first topic. Throughout, passages were
marked in the transcripts with labels or comments
relating to the respective themes. Finally, a meeting was
held were all authors discussed the themes and
interpretations.
Results
All organizations asked to participate agreed to do so. The
participants are divided into one of three stakeholder
groups (see Table 1); political, patient, or professional
organization representatives. Altogether, six political, three
professional and three patient organization representatives
were interviewed, one from each organization; four
women and eight men. Quotations have been chosen to il-
lustrate the different opinions. Also, the organizations’
general views on the reform before it took place were
analyzed through the Committee Report responses. This
is presented in Table 1.
The results section begins with a description of the par-
ticipants’ (retrospective) expectations of the liberalization
reform – first the positive, and then the negative expecta-
tions. After that, the perceived outcomes of the
liberalization and non-prescription medicines reform are
presented – first the anticipated outcomes, and then out-
comes that the stakeholders had not foreseen.
The main results are summarized in Table 2.
Before the reforms: positive expectations
The participants’ expectations of positive results in-
cluded improved pharmacy services through innovations
and new ideas, better access through more pharmacies
and better use of pharmacists’ knowledge.
Among both participants from the political and the
professional organizations in favor of the liberalization,
the change of ownership per se was mentioned as a ra-
tionale. However, the motives for this stance were not
the same. Participants from the political organizations in
favor of the ownership liberalization clearly stated that
this reform was not done because the pharmacy monop-
oly had large insufficiencies. Instead, it was performed as
a consequence of the premise that government should
not own pharmacies. “The reregulation1 is done primar-
ily […] not to save money, but in order to create oppor-
tunities for ideas, development and to create
accessibility” (interview 1). It was also mentioned that
there was not a strong public opinion in favor of the
liberalization of ownership.
Among participants from the professional organiza-
tions, the idea that pharmacists wanted to have the op-
portunity to own pharmacies was presented. “I think
that the feeling of being able to decide by oneself was
important” (interview 8). They stated that it was hoped
that the liberalization would lead to innovations and a
better use of the pharmacists’ knowledge – e.g., better
counseling - if pharmacists were allowed to own their
own pharmacies. Participants from the political organi-
zations also used this expectation as a rationale for the
liberalization; because a professional organization is
strongly in favor of the liberalization, this reform must
be worthwhile.
Before the reforms: negative expectations
In the interviews, the major concerns the participants
stated they had before the reform, included fear of an
oligopoly market without enough competition, and fear
of negative health effects because of the sale of non-
prescription medicines outside pharmacies.
One fear that was expressed among participants from
the political organizations was that the liberalization
would not lead to any improvements, as the monopoly
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was in fact functioning so well. Those representing polit-
ical organizations in favor of the liberalization brought
up the concern that the monopoly might be replaced by
an oligopoly. It was stated that in the post-liberalization
market it would be almost impossible for small enter-
prises to survive because of economies of scale and diffi-
culties in creating market segmentation. However, one
of the political proponents for the liberalization also
feared that the small enterprises might not want to de-
velop new ideas and innovations. “Maybe they just
thought: Wow, now we can take over and earn some
money” (interview 1).
Participants also expressed that the accessibility goal,
defined as an increased number of pharmacies, could be
at risk when non-prescription medicines were allowed to
be sold outside the pharmacies, and that this would de-
crease the profitability of the pharmacies. The loss of
profit could increase the risk of pharmacies closing
down. “We saw disadvantages regarding removing some-
thing profitable from the pharmacies” (interview 2).
After the reforms: positive and neutral outcomes
In this section, the perceived effects (as reported by the
participants) of the ownership liberalization and the
non-prescription medicines reform are described.
The competition introduced in the market was seen by
some of the political organizations as making the phar-
macies adjust to the needs of the patients, e.g., adjusting
opening hours and improving treatments of patients. “If
you have another pharmacy in close proximity, then you
try to improve your communication with these patients”
(interview 5).
The opinion that the new competition might have had
positive effects in the use of medicines was prevalent
among the political participants. “A successful pharmacy
must make the patients want to return and meet the phar-
macists […] And I think that this is a strong driving
force for better use of medicines” (interview 4). One
of the political organizations stated that starting to
sell non-prescription medicines outside pharmacies
could have improved public health. “If you measure
improved public health by the ability to cure a head-
ache or a stuffy nose quickly, then public health has
improved“(interview 6).
An increased focus on offering non-medicines in the
pharmacies was mentioned among all stakeholder
groups as an effect of the reform. According to one of
the governmental political representatives, this was ex-
pected: “…a general shift towards sales of more commer-
cial goods in the pharmacies. And that was quite
expected” (interview 3).
One effect mentioned by the participants was that
smaller pharmacies make stock adaptation harder, which
makes accessibility of prescription medicines more diffi-
cult than before. Participants from political organizations
saw it as a natural consequence that pharmacies – in
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order to increase in numbers – would be smaller and
would therefore not be able to afford big stocks.
After the reforms: negative outcomes
None of the participants thought that the increased
number of pharmacies had improved public health. Dif-
ferent opinions existed regarding both the amount of
health-care-related activities, and whether these would
affect public health. A presumption was that the increase
in pharmacies was not done in order to improve health,
but solely to be profitable. Also, among the political or-
ganizations, it was mentioned that the perceived increase
in pharmacy-based medical tests was done for the”-
wrong” reason – in order to be profitable, instead of be-
ing to increase the health of the population. “It is
seldom that we recommend everybody for screening. It
has become a purpose of its own” (interview 6).
Even though no questions were asked about the non-
prescription medicines reform, many of the participants
discussed this reform. Among the patient and profes-
sional organizations, possible negative consequences for
health were mentioned, as non-prescription medicines
are sold at grocery and other stores without the possibil-
ity of getting counseling. “We have increased the adverse
effects for many [patients]” (interview 11). A few of the
political party representatives did not believe sale of
non-prescription medicines outside of pharmacies had
negative health effects.
After the reforms: negative unexpected outcomes
The negative unexpected effects, according to the inter-
viewees, included a lack of innovation, and a perceived
decrease in accessibility of prescription medicines.
All the participants concluded that the post-
liberalization pharmacy market consists of pharmacy
chains that are very much alike. The participants were sur-
prised by the lack of specialization/diversity; for example
that not many new health-related services had been intro-
duced. Instead the new pharmacies were seen as very
much resembling the “old” state-owned pharmacies.
There were, however, hopes that a more significant
specialization would develop in the future.
One perceived reason for the lack of specialization was
that the pharmacies’ low profitability made them focus
on “safe” areas. Another explanation expressed among
the professional organizations, was that a majority of the
new pharmacies belong to big chains: “In that shopping
mall there are now two pharmacies […]. There is no rea-
son in the world that people need two” (interview 12).
A third explanation among the participants from polit-
ical organizations, was a lack of competition, e.g., among
the wholesalers.
All the participants from professional-, and some from
the patient organizations, thought that counseling in the
pharmacies had deteriorated after the liberalization. Rea-
sons given for this included the increased required rate
of return (from pharmacy owners), and less focus on
professional activities.
Participants from all professional, and from one polit-
ical organization, considered the liberalization to be
negative, as the pharmacists’ accessibility to patients in a
pharmacy decreased. “You don’t get the counseling you
need” (interview 8).
Some of the participants from patient organizations
also viewed the change as negative for their members,
because the pharmacists’ ability to focus on pharma-
ceutical information was reduced. “The focus on
profit should not be so overwhelming that you don’t
bother to look in FASS [Pharmacopeia Drug Informa-
tion]” (interview 10). This change in focus was viewed
as having affected the use of medicines in a negative
direction.
Among the professional organizations’ participants,
the move away from professional activities in pharma-
cies, to more focus on just selling products, was seen as
a consequence of the reforms. The change in focus was
among all stakeholder groups seen as damaging for the
pharmacists’ ability to focus on professional skills.
Participants from all stakeholder groups mentioned
that medicines are perceived as less available in the
pharmacies after the liberalization. The fact that the
pharmacies are smaller, and hence their stocks are also
smaller was mentioned among all the participant groups
as the main reason for the perceived deterioration. “We
don’t have medicines in the pharmacies as much as we
had before” (interview 7).
Three main reasons were presented by the participants
for this perceived effect. Firstly, the competition intro-
duced in the market was (among a few political repre-
sentatives) seen as a possible reason, as pharmacies are
now more cost-conscious, and therefore have smaller
stocks. At the same time, participants from the political
organizations were generally surprised that the competi-
tion had not led to more pronounced stock adjustment
according to patients’ needs. Also, among participants
from the political organizations in favor of the
liberalization it was stated that the large patient majority
had not been affected, but that it is a natural conse-
quence of a market that it is harder for small patient
groups to get their medicines. “Some patient groups
could be affected negatively” (interview 3).
The other main reason mentioned for the perceived
lower accessibility of medicines was that the change in
the reimbursement of generic medicines had led to this
effect, and that it could induce pharmacies to have
smaller stocks. “Next week there will be a new generic
[…] so maybe you take the chance and have just a small
amount” (interview 1).
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The third explanation given was that a higher expect-
ation among the patients made them perceive accessibil-
ity of medicines as lower.
Lastly, deteriorating collaboration between the com-
munity pharmacies and other parts of the health-care
sector was mentioned by a political organization partici-
pant, who described the connection as less or un-
changed since the liberalization.
Also, some of the patient and all of the professional
organizations’ participants stated that the collaboration
with the rest of the health-care system was lower after
the liberalization. “The pharmacies’ role in the health-
care system has become weaker” (interview 11). “Now-
adays we don’t have time for anything but to dispense”
(interview 8).
Discussion
The perceived effects of the liberalization of ownership
were experienced as quite similar by all stakeholder
groups, i.e., no differentiation of services, lower accessi-
bility of medicines – but better access to pharmacies,
and a commercialization of pharmacies. These effects
are in line with those in other liberalized markets [1].
The results show that only a few of the expected effects
were considered to be fulfilled, according to the partici-
pants; instead, other, unexpected effects were observed.
The similarity of opinions is notable as the different
stakeholder groups have different ideological as well as
practical interests in the pharmacy sector.
To get a development of ideas and diversity was an
important underlying rationale for both the political and
professional proponents of the reform, as shown in the
results. However, all participants from these stakeholders
expressed, that the pharmacy sector has not developed
in this direction after the liberalization. The two stake-
holder groups did not share the same view on how the
reform could have led to diversity. The participants
representing political proponents stated that diversity
would be developed through creation of a market, and
the professional representatives hoped that it would have
happened if only the profession got to own pharmacies.
This shows that not only the underlying rationales, but
also the mechanism for the change is important to
investigate.
Less accessibility of medicines and less freedom of choice
A common rationale behind NPM-inspired reforms is
the introduction of provider choice [25]. However, just
getting more pharmacies in the market does not corres-
pond to freedom of choice, because real choice implies a
possibility to choose between alternatives that are differ-
ent. On the contrary, there has even been a diminished
opportunity for choice as the change in generic
substitution makes it harder for patients to choose any-
thing other than the cheapest drug.
The smaller stocks in the pharmacies were by some
participants seen as a natural consequence of the reform,
while others were surprised by this consequence of the
liberalization. These two effects resulting in less accessi-
bility to medicines (less medicines in stock) and possibly
less freedom of choice were not discussed or thoroughly
investigated prior to the reform, and can hence be seen
as negative unexpected effects. The fact that accessibility
of medicines was not perceived as a problem prior to
the reform is a probable explanation as to why this was
not discussed beforehand.
Increased efficiency and price pressure were present as
rationales in the beginning of the preparatory work pre-
ceding the reform [20]. Despite this, none of the partici-
pants mentioned these arguments as a rationale for the
reform. This could be explained by the fact that the in-
vestigation leading to the reform showed the impossibil-
ity of combining more pharmacies and lower public
expenses, illustrated in the increase in reimbursement to
the pharmacies linked to the liberalization.
The fact that two major rationales were shown to be
unfulfilled even before the details of the reforms were
decided on did not make the government change its
mind. It seems as though they were simply deleted from
the agenda, and the change of rules for generic substitu-
tion was launched, in order not to obtain higher overall
costs. The price pressure on generics accomplished not
least through the state (via a governmental agency) ne-
gotiating prices hence seems to be comprehended as
more efficient than a NPM-inspired pharmacy sector.
Two reforms – one argument
Some participants discussed the reform on non-
prescription medicines, even though questions only were
asked about the ownership liberalization. It seems as par-
ticularly the political representatives confused the owner-
ship liberalization reform with the non-prescription
medicines reform; arguments for selling non-prescription
medicines outside pharmacies, e.g., accessibility, were used
to argue for the liberalization of the ownership. This is in-
teresting, as in reality it is not one reform, or even two re-
forms that are naturally connected. On the contrary, it
would have been possible to liberalize only the sale of
non-prescription medicines, or to liberalize only the phar-
macy ownership. The former was, for example, the case in
Denmark [26].
Deprofessionalization a result of the liberalization reform
As the results show, both the expected and perceived ef-
fects of the ownership liberalization were that the phar-
macists’ focus on dispensing and counseling regarding
prescription medicines was perceived as diminished, in
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favor of less professional activities. Two examples of
deprofessionalization trends could be seen in the
interviews.
Firstly, participants appeared to experience an in-
creased focus on sales of commercial goods in pharma-
cies. A decreased counseling was highlighted by both the
patient and professional organizations as an effect of the
reform. The non-prescription medicines reform was
seen as one cause for the perceived shift towards more
unskilled work tasks; pharmacies have to sell more non-
medicines in order to increase profits. If this perception
is true this shift might affect the health of the population
in a negative direction, as decreased counseling also
means that less drug-related problems are detected, and
hence medication-related illnesses can increase.
The second deprofessionalization effect reported by
participants is that the non-prescription medicines re-
form could be seen as a loss of a professional domain
for pharmacy staff, because non-prescription medicines
are now sold in grocery stores, without professional
pharmacy staff.
As in Iceland, the Swedish professional organizations
differed in their opinions regarding the liberalization re-
form before it took place [27, 28]. It should be noted
that the political organization representatives declared
other rationales for the reform, compared to those from
professional organizations, in favor of liberalization. The
former argued that entrepreneurs are important in
general, but not pharmacist ownership in particular.
The latter argued that non-NPM values, such as bet-
ter use of the pharmacists’ knowledge, and, as shown
in their Committee Report, encouraging professionals,
i.e., pharmacists, to own pharmacies were important
rationales [29].
The original, openly stated, motives could have been
met with other types of policy changes. For instance,
non-prescription medicines could have been liberalized
for increased accessibility, more pharmacies could have
been opened by the state-owned pharmacy company,
and drug use services implemented in the same pharma-
cies, and the changes to reimbursement for generic sub-
stitution could have pressured prices further.
Because pharmacies are a part of the health-care sec-
tor, it is interesting to note that the political representa-
tives did not consider that the liberalization of
ownership could lead to health effects, neither positive
nor negative. In the results, this is shown e.g., when a
political organization in favor of the reforms is aware
that it will lead to a commercialization of the pharma-
cies, without considering this as a potentially negative ef-
fect. It could also be noted that health was not part of
the official (governmental documents’) rationale for the
reform. Instead some participants from political organi-
zations seemed content with the increased number of
pharmacies, but did not reflect on the possible impact
on public health – illustrating that pharmacies are not
seen as important actors when it comes to public health.
It seems as if liberalization of ownership was wished
for, for its own sake, whether the post-liberalization mar-
ket was more efficient or not. It should be noted that
even strong privatization proponents conclude that there
is a lack of evidence that privatization reforms lead to
greater effectiveness/efficiency [4].
Limitations
There are some limitations to this study; only one person
within each organization was interviewed, and their views
might not reflect those of the whole organization. How-
ever, most of the participants had been involved through-
out the reform, and they were chosen as key participants
by their respective organizations. Another limitation is a
possible memory bias regarding the questions about the
period before the liberalization. The risk of this bias is di-
minished by involving the consultation responses, i.e.,
how the organizations positioned themselves in the re-
form process. These individualized questions also helped
the participants to recall the process, which also probably
strengthened the validity of the study.
Conclusion
The perceived effects of the pharmacy sector reform
were quite similar in the different stakeholder groups,
and the results show that they are generally not as posi-
tive after the liberalization as before. It could be argued
that the effects of this specific reform should have been
more thoroughly investigated, e.g., the effect on the ac-
cessibility of prescription medicines in the pharmacies. It
is a lesson to be learnt for pharmaceutical policy makers
– and others involved – also in other settings: the im-
portance of investigating those aspects that are not the
focus of a reform, in order to foresee consequences –
desired or not.
However, despite discrepancies between expected and
perceived effects, it seems as though no one takes re-
sponsibility for the perceived negative effects. Instead,
some participants stated that the positive expectations
will be fulfilled in the future – without explaining why
and how this will happen. There is a need to investigate
possible effects before doing this kind of reform, and to
include experts that are knowledgeable of the area.
In the interviews, it was clear that some of the partici-
pants had limited knowledge about how the pharmacy
sector functions. A lesson to be learned is that it is vital
that the pharmacy profession is active in questions re-
garding pharmaceutical and pharmacy policy. In this
way, politicians could be helped to work in a more
evidence-based way instead of introducing reforms solely
based on ideology [30].
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Endnotes
1In the interview material, different words were used
for the ownership liberalization; − i.e., reregulation and
deregulation.
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